Screener
Rhythm Pharmaceuticals, Inc. RYTM Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-030549
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Short-term investments | 278,488 | 334,648 |
| Accounts receivable, net | 34,192 | 26,081 |
| Inventory | 28,651 | 25,753 |
| Prepaid expenses and other current assets | 26,622 | 26,133 |
| Total current assets | 430,090 | 466,916 |
| Property and equipment, net | 1,065 | 1,104 |
| Right-of-use asset | 2,936 | 3,049 |
| Intangible assets, net | 5,106 | 5,319 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s prepaid & other current?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported prepaid & other current of $26.62M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s prepaid & other current increased by 50.8% year-over-year, from $17.66M to $26.62M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s prepaid & other current?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s prepaid & other current has grown at a 24.1% compound annual growth rate (CAGR), from $8.88M to $26.13M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude